Effect of androgen replacement therapy on atherosclerotic risk markers in young‐to‐middle‐aged men with idiopathic hypogonadotropic hypogonadism

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2265|82|3|422-428

ISSN： 0300-0664

Source： CLINICAL ENDOCRINOLOGY, Vol.82, Iss.3, 2015-03, pp. : 422-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

INDUCTION OF SPERMATOGENESIS IN IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM WITH GONADOTROPINS IN OLDER MEN

By SAMLI M.   DEMIRBAS M.   GULER C.  

Archives of Andrology, Vol. 50, Iss. 4, 2004-07 ,pp. : 267-271

Informa Healthcare

Access to resources Recommend Favorite

Reversal of isolated hypogonadotropic hypogonadism: long‐term integrity of hypothalamo–pituitary–testicular axis in two men is dependent on intermittent androgen exposure

By  

CLINICAL ENDOCRINOLOGY, Vol. 81, Iss. 3, 2014-09 ,pp. : 473-476

John Wiley & Sons Inc

Access to resources Recommend Favorite

Androgen Replacement Therapy in Late-Onset Hypogonadism: Current Concepts and Controversies – A Mini-Review

By  

Gerontology, Vol. 57, Iss. 3, 2010-08 ,pp. : 193-202

Karger

Access to resources Recommend Favorite

Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4‐month randomised trial in middle‐aged men

By  

THE PROSTATE, Vol. 75, Iss. 12, 2015-07 ,pp. : 1255-1263

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dietary Folate and the Risk of Depression in Finnish Middle-Aged Men

By  

Psychotherapy and Psychosomatics, Vol. 73, Iss. 6, 2004-10 ,pp. : 334-339

Karger

Access to resources Recommend Favorite